Latest stories on COCP
Cocrystal Pharma Completes Dosing in Norovirus Phase 1b Study
TipRanks58 · neutralproduct/pr
Cocrystal Pharma, Inc. (COCP) files 8-K
SEC 8-K50 · neutralgeneral
Cocrystal Pharma doses last subject in norovirus challenge study
The Fly63 · neutralproduct/pr
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
GlobeNewswire63 · neutralproduct/pr
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Yahoo Top56 · neutralgeneral
Cocrystal Pharma, Inc. (COCP) files 8-K
SEC 8-K50 · neutralgeneral
Cocrystal Pharma, Inc. (COCP) files 8-K
SEC 8-K50 · neutralgeneral
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
StockTitan55 · neutralgeneral
OPKO Health Boosts Stake in Cocrystal Pharma Financing
TipRanks63 · neutralgeneral
Cocrystal Pharma, Inc. (COCP) files 8-K
SEC 8-K50 · neutralgeneral
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Business Insider56 · neutralgeneral
Cocrystal Pharma Shareholders Approve Governance and Oversight Measures
TipRanks50 · neutralgeneral
Cocrystal Pharma, Inc. (COCP) files 8-K
SEC 8-K50 · neutralgeneral
Cocrystal Pharma, Inc. (COCP) files 8-K
SEC 8-K50 · neutralgeneral
Cocrystal Pharma Names New CEO to Drive Antiviral Pipeline
TipRanks56 · neutralgeneral
Cocrystal Pharma Reports Promising Pan-Viral Antiviral Activity
TipRanks67 · bullishproduct/pr
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza | COCP Stock News
StockTitan63 · neutralproduct/pr
Cocrystal Pharma GAAP EPS of -$0.17 misses by $0.02, revenue of $0.23M
Seeking Alpha34 · bearishearnings